Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis

Clinical trial NCT00477191 · TERMINATED

Trial details

NCT number: NCT00477191
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Psoriasis Metabolic Syndrome Hyperlipidemia Obesity Hypertension

Start date: 2007-05-01
Primary completion: 2013-12-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.